# Transplantation of Autologous Bone Marrow or Leukapheresis-Derived Stem Cells for Treatment of Spinal Cord Injury

> **NCT02687672** · PHASE2 · UNKNOWN · sponsor: **Stem Cells Arabia** · enrollment: 50 (estimated)

## Conditions studied

- Spinal Cord Injury

## Interventions

- **BIOLOGICAL:** Stem Cell Transplantation

## Key facts

- **NCT ID:** NCT02687672
- **Lead sponsor:** Stem Cells Arabia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01
- **Primary completion:** 2021-06
- **Final completion:** 2021-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2020-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02687672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02687672, "Transplantation of Autologous Bone Marrow or Leukapheresis-Derived Stem Cells for Treatment of Spinal Cord Injury". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02687672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*